Star Scientific, Inc. (NASDAQ:STSI) is down by 4.49%, Cardium Therapeutics Inc (NYSEMKT:CXM)

Posted by Ryan Mandell May 31, 2013 0 Comment 839 views


Hartford, CT 05/31/2013 (GDPInsider) – Star Scientific, Inc. (NASDAQ:STSI) is down by 4.49% and closed at $1.49. It hit a high of about $1.58 and low of $1.42. It is about 33.91% above its 52 week low of $1.15 and about 69.50% below its 52 week high of $5.05. Around average volume of 1.15 million shares have exchanged over a period of 30 days. The return on equity is about -124.28% which shows that the company is unable to generate a positive return on the equity of the shareholders. The short ratio is standing at 21.82 and about 23.19% of the shares floated are held short. The relative strength index of the stock is 59.50.

With the introduction of Anatabloc Revitalizing Facial Serum, Star Scientific expanded cosmetic products line. Both the Anatabolic facial serum and the Antabolic facial crème are available at company’s product web site.

Is STSI a solid investment at these levels? Get valuable updates and exclusive insights here.

Cardium Therapeutics Inc (NYSEMKT:CXM) is down by 5.56% and closed at $0.0850. It hit a high of about $0.09 and low of $0.09. It is about 49.40% above its 52 week low of $0.06 and about 67.96% below its 52 week high of $0.28. Around 0.169 million shares have exchanged hands so far which are lower than average volume of 0.596 million shares measured over a period of 30 days. The return on equity is about -156.40% which shows that the company is unable to generate a positive return on the equity of the shareholders. The short ratio is standing at 4.26 and about 1.82% of the shares floated are held short. The relative strength index of the stock is 39.89.

Cardium Therapeutics is the company which focuses on development of business opportunities. It is planning to develop MedPodium in a science based culture of medicinals, metabolics and aesthetics

How Should Investors Trade CXM Now? Get key and important information right here.

Disclosure:

WallStreetAnalyzed.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetAnalyzed.com website, for complete risks and disclosures.


About Ryan Mandell

Ryan Mandell is our senior staff writer covering the White House for Political Report, Ryan also coordinates with the main newsroom news items and contributing write-ups on cultural, social and political activities. Ryan holds an undergraduate degree in journalism, a Doctorate in international relations and a Master Degree in mass communications with an emphasis in print journalism. Ryan also covered the International Society of Social Defense congress in Spain in 2007 and taken part in the Global Forum on economic policies

View all post by Ryan Mandell Visit author's website

Write Your Comment